Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ali R, Sever"'
Autor:
Hatice Gümüş, Philippa Mills, David Fish, Metehan Gümüş, Karina Cox, Haresh Devalia, Sue jones, Peter Jones, Ali R. Sever
Publikováno v:
Diagnostic and Interventional Radiology, Vol 22, Iss 1, Pp 29-34 (2016)
Externí odkaz:
https://doaj.org/article/d7e817181af247508aca63a519f72e3f
Autor:
Ashutosh Kothari, Ali R Sever, Tibor Kovacs, Sarah E Pinder, Catrin Morgan, Rajesh Balasubramanian, Elina Shaari, Hisham Hamed
Publikováno v:
European Journal of Surgical Oncology. 46:1028-1033
Aim This study investigated whether wire localisation of the histologically proven positive, clipped axillary lymph node (ALN) with subsequent targeted axillary dissection (TAD) following neoadjuvant chemotherapy (NACT) improves axillary staging in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c7e1c9beafb9ae88bfbaec4d89a48d
https://doi.org/10.1016/j.ejso.2019.12.007
https://doi.org/10.1016/j.ejso.2019.12.007
Autor:
Gökmen Umut Erdem, Ali R Sever, Yavuz Ozisik, Fatih Karatas, Aydin Aytekin, Kadri Altundag, Suleyman Sahin
Publikováno v:
The Breast. 32:227-236
Background:Body mass index (BMI) is defined as a poor prognostic factor in patients with breast cancer(BC). However, there are controversial results regarding the various effects of BMI on BC, hence the exactpathophysiology of the relation between ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0732c244c9b520f9a31e3e7049d4e4b
https://doi.org/10.1016/j.breast.2016.09.019
https://doi.org/10.1016/j.breast.2016.09.019
Publikováno v:
Supportive Care in Cancer. 24:3481-3488
The aims of this study were to explore advanced breast cancer patients’ knowledge of treatment intent and expectation of illness course and to evaluate their relationship with optimism, hope, and quality of life (QoL). Patients with advanced breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f01563013c1e9a95f5c31fb9c4d164a
https://doi.org/10.1007/s00520-016-3182-6
https://doi.org/10.1007/s00520-016-3182-6
Publikováno v:
Current Medical Research and Opinion. 32:133-145
Denosumab is fully human monoclonal antibody that specifically binds and inactivates receptor activator of NF-kB ligand (RANKL), an important ligand that regulates bone remodeling. In this review, we aimed to show the clinical data about denosumab tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa7533fb3733cf87d7154c5de750e0f
https://doi.org/10.1185/03007995.2015.1105795
https://doi.org/10.1185/03007995.2015.1105795
Autor:
Ibrahim, Petekkaya, Ozan, Unlu, Emir C, Roach, Gizem, Gecmez, Alexis K, Okoh, Taner, Babacan, Furkan, Sarici, Ozge, Keskin, Cagatay, Arslan, Emine, Petekkaya, Ali R, Sever, Kadri, Altundag
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 22(3)
The effects of inflammation on the prognosis, life expectancy and several parameters such as response to treatment of breast cancer have been previously studied. The purpose of this study was to investigate the effect of inflammatory markers on progn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::672d7b71255d837cc5fbecff21fa36be
https://pubmed.ncbi.nlm.nih.gov/28730765
https://pubmed.ncbi.nlm.nih.gov/28730765
Autor:
Gokmen U, Erdem, Kadri, Altundag, Nuriye Y, Ozdemir, Suleyman, Sahin, Nebi S, Demirci, Fatih, Karatas, Yakup, Bozkaya, Aydin, Aytekin, Vildan, Tasdemir, Alma C, Aslan, Ali R, Sever, Nurullah, Zengin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 22(2)
It is well-known that tumor phenotype may change during the progression of breast cancer (BC). The purpose in this study was to compare the discordance in estrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ff458c70d7e4129daea99c1303c2412
https://pubmed.ncbi.nlm.nih.gov/28534357
https://pubmed.ncbi.nlm.nih.gov/28534357
Publikováno v:
Future Oncology. 11:2495-2497
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7c1067d2286bd06ea8635847cc3b26
https://doi.org/10.2217/fon.15.164
https://doi.org/10.2217/fon.15.164
Autor:
Fatih, Karatas, Sanja, Sahin, Gokmen U, Erdem, Ozturk, Ates, Taner, Babacan, Serkan, Akin, Ali R, Sever, Yavuz, Ozisik, Kadri, Altundag
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(4)
Development of metastasis in patients with breast cancer (BC) is the most important negative prognostic factor and this process mainly begins with lymphatic involvement. Therefore, axillary, subclavicular, internal mammary or supraclavicular nodal in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f39d59f678c162fe3cb37bd77c99ce99
https://pubmed.ncbi.nlm.nih.gov/27685905
https://pubmed.ncbi.nlm.nih.gov/27685905
Autor:
Mehmet, Ozen, Mehmet, Gunduz, Ozturk, Ates, Taner, Babacan, Ali R, Sever, Serkan, Akin, Yavuz, Ozisik, Kadri, Altundag
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(4)
Optimal duration of adjuvant trastuzumab therapy in early-stage HER2-positive, lymph node-negative breast cancer is unknown. To establish this, we compared 1-year and 9-week trastuzumab regimens in HER2-positive, lymph node-negative early-stage breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bea8d294336e3bd1fee8e855f0f5a890
https://pubmed.ncbi.nlm.nih.gov/27685899
https://pubmed.ncbi.nlm.nih.gov/27685899